TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 22 | 53 | 33 | 23 | -7 | 21 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/22 07:12 | 5/27/22 | AVDL | Avadel Pharmaceuticals Plc | Health | Drug | Pharmaceutical Preparations | Thornton Peter J. | L2 | D | P | 85 | 1.69 | 0 | 50 | 151 | 83 | D | ||||||||||||||||
9/25/17 16:58 | 9/21/17 | AVDL | Avadel Pharmaceuticals Plc | Health | Drug | Pharmaceutical Preparations | Thornton Peter J. | L2 | D | P.d | 50 | 9.74 | 0 | 5 | New | 5 | D | ||||||||||||||||
10/25/04 08:47 | 10/22/04 | AGEN | Antigenics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Thornton Peter | NY | O | CFO,SVP | P | 26 | 5.70 | 1 | 5 | 900 | 5 | D | -36 | -55 | -44 | -21 | -16 | -10 | -5 | 14 | 1 | 22 | 53 | 33 | 23 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |